Hereditary Cancer in Clinical Practice (Apr 2012)
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Abstract
No abstracts available.
Hereditary Cancer in Clinical Practice (Apr 2012)